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Fluorocarbons are lipophobic and non-polar molecules that exhibit remarkable biocompat-
ibility, with applications in liquid ventilation and synthetic blood. The unique properties of
these compounds have also enabled mass spectrometry imaging of tissues where the
ﬂuorocarbons act as a Teﬂon-like coating for nanostructured surfaces to assist in desorption/
ionization. Here we report ﬂuorinated gold nanoparticles (f-AuNPs) designed to facilitate
nanostructure imaging mass spectrometry. Irradiation of f-AuNPs results in the release of the
ﬂuorocarbon ligands providing a driving force for analyte desorption. The f-AuNPs allow for
the mass spectrometry analysis of both lipophilic and polar (central carbon) metabolites.
An important property of AuNPs is that they also act as contrast agents for X-ray micro-
tomography and electron microscopy, a feature we have exploited by infusing f-AuNPs into
tissue via ﬂuorocarbon liquids to facilitate multimodal (molecular and anatomical) imaging.
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F
luorocarbons have remarkable chemical and physical
characteristics that allow unique surface properties, high
stability, low reactivity and an ability to solubilize gases. The
biocompatibility of ﬂuorocarbons has been demonstrated1–5 and
has inspired researchers to utilize these compounds for a wide
range of biomedical and research applications. For example,
these properties have enabled ﬂuorocarbons to be applied in areas
as diverse as surface coatings6, drug delivery4, liquid ventilation1,
synthetic blood2 and several imaging modalities4,5,7,8 including
mass spectrometry imaging9.
Mass spectrometry imaging facilitates the spatially resolved
mass analysis of metabolites in situ10–12 where investigators have
a choice of multiple technologies each with their inherent
advantages and disadvantages9,13–18. These techniques include
matrix-assisted laser desorption/ionization mass spectrometry
(MALDI-MS)15, secondary ion mass spectrometry13, desorption
electrospray ionization14, MALDESI18, and others9,16,17,19. While
there have been some successful developments in low energy20
and low background21 matrices for MALDI-MS, the most widely
used of these technologies, these matrices do not facilitate
multiple modes imaging.
Gold nanoparticles (AuNPs) are well known as contrast agents
for X-ray imaging technologies22–24 and electron microscopy25.
For example, the attenuation property of X-rays by AuNPs has
led to their use as contrast agents in computed tomography (CT)
imaging26,27. AuNP have also been exploited for mass
spectrometry molecular imaging, thus presenting a single
platform capable of supporting comprehensive bioimaging.
However, AuNPs’ ability to facilitate molecular imaging via
mass spectrometry is limited due to the required high laser
energies, resulting in signiﬁcant fragmentation and generally poor
sensitivity28. While AuNPs are attractive biomedical imaging
agents, they have not been explored as agents to correlate
structure with molecular information given their limitations with
mass spectrometry. Indeed, when performing mass spectrometry-
based metabolomic imaging, correlating metabolite localization
patterns with tissue anatomy is key to data interpretation but
has represented a serious challenge. Traditionally, correlations
have been based on immunohistochemistry. Given that
immunohistochemistry chemically alters tissue sections
immunohistochemistry and mass spectrometry imaging cannot
be performed on the same tissue samples.
Here we introduce f-AuNPs as an agent for nanostructure
imaging mass spectrometry (NIMS). The use of ﬂuorocarbons as
a covalent modiﬁcation of AuNPs for this application is a natural
choice given the history17 of ﬂuorocarbons facilitating NIMS,
speciﬁcally nanostructured silicon has beneﬁted from ﬂuorine
modiﬁcations9. Fluorinated silicon nanostructures used for laser
desorption/ionization have been shown to generate low
background interference, have minimal ultraviolet absorbance,
generate little fragmentation and, given their unique super-
hydrophobicity, readily allow for the desorption of metabolites
from their surface with high sensitivity. In addition, ﬂuorous
initiators containing amino groups can be used to promote
[MH] production29,30, which, similar to basic MALDI
matrices31,32, have been successfully applied to mass
spectrometry imaging of central carbon metabolites. In addition
to mass spectrometry imaging, f-AuNPs, unlike MALDI
matricies, are also capable of acting as contrast agents for X-ray
analysis and electron microscopy22–24,25. We demonstrate
f-AuNP multimodal imaging to generate X-ray (mCT) and
electron microscopy structural images, as well as facilitating
mass spectrometry imaging, providing both anatomical and
molecular information.
Results
Fluorinated AuNPs for mass spectrometry imaging. Given the
advantages that ﬂuorocarbon modiﬁcations impart on silicon
nanostructure mass spectrometry imaging, our goal in these
studies was to adapt ﬂuorocarbon ligands to the more versatile
AuNPs. In laser desorption/ionization experiments, silicon
nanostructures and AuNPs absorb energy extremely well in the
ultraviolet region33–35 and in the case of AuNPs, the core can
reach B2,000K in a few nanoseconds36. While AuNPs alone
have limited ability to facilitate molecular imaging via mass
spectrometry due to the required high laser energies resulting in
signiﬁcant fragmentation and generally poor sensitivity28. AuNPs
with ﬂuorocarbon ligands (f-AuNPs) are designed to initiate the
desorption/ionization mass spectrometry event while attenuating
energy transfer to the analyte. This is accomplished through the
ﬂuorinated ligand, which serves to insulate the analyte from the
thermal energy of the AuNP (B2,000K) while the laser-induced
release of the ligand allows it to act as a conduit for analyte
desorption. We posit that the thermal desorption of the ligand
provides enough kinetic energy to drive analyte desorption into
the gas phase with minimal energy input, as illustrated in Fig. 1.
In a representative experiment, we have demonstrated the
utility of these f-AuNPs to carry out MS analysis of pure
standards (Supplementary Fig. 1) and human plasma
(Supplementary Fig. 2) using two instruments designed for
MALDI, an AB SCIEX TOF/TOF 5800 and a Waters Synapt G2.
AuNPs also offer a straight-forward platform for functionaliza-
tion using gold-thiol chemistry. Here we used two separate
commercially available thiols, 1H,1H,2H,2H-perﬂuorodeca-
nethiol (fC10) and 1H,1H,2H,2H-perﬂuorooctanethiol (fC8).
However, there is also the opportunity to design new ligands
for the AuNPs that could enhance ionization, for example, amine
ﬂuorocarbon ligands could facilitate desorption/ionization of
negatively charged metabolites since the ligand’s amine would act
as a proton acceptor.
Soft ionization with ﬂuorinated AuNPs. To illustrate the laser-
induced thermal energy generated at f-AuNPs, 4-nm f-AuNPs
were measured with transmission electron microscopy (TEM)
before and after laser irradiation (Fig. 2). The size distribution in
the top panel of Fig. 2 shows an increase in size (to B6 nm)
indicating that the particles melt and anneal following exposure
to the laser pulses. The accompanying TEM images in Fig. 2b
offer further evidence that laser radiation has melted and fused






Figure 1 | Decoupling laser-induced nanoparticle heating from
desorption/ionization. Schematic illustration of the possible desorption
mechanism: on irradiation, gold core efﬁciently absorbs the laser energy
and transfers the energy to thermally release ﬂuorinated ligands. The
desorbed ﬂuorinated ligands provide the kinetic energy (and driving force)
for analyte desorption and serve to protect the analyte from thermal
degradation. Protonated diacetylspermine is shown as an example of
f-AuNP desorption/ionization.
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particles can be used to desorb the ﬂuorocarbon ligand, thus
indirectly desorbing analyte molecules into the gas phase for mass
spectrometry analysis. Thermal desorption, however, typically
requires high energy, which leads to signiﬁcant fragmentation,
including the formation of ions that are primarily cation
adducts33 and the formation of gold cluster ions37. Therefore, our
next set of experiments explored the performance of the f-AuNPs
and whether thermal release of the ﬂuorocarbon ligand was
beneﬁcial to the mass spectrometry analyses. To do this, the
f-AuNPs were compared with MALDI and AuNPs functionalized
with the non-ﬂuorous ligand octanethiol (C8-AuNPs) by tracking
the survival yield of the thermally labile molecule methoxybenzyl
pyridinium with respect to laser energy (Fig. 2). Survival yield was
calculated as the ratio of [M]þ (m/z¼ 200) to the major
fragment at m/z¼ 121. Desorption of methoxybenzyl pyridinium
was initiated at energies above 0.78 mJ; when using MALDI
with a-cyano-4-hydroxycinnamic acid, (C8-AuNP) initiated
desorption at energies above 0.50 mJ, while the f-AuNP initiated
desorption at energies above 0.25 mJ for the 8-carbon ﬂuorous
ligand (F8-AuNP) and 0.34 mJ for the 10-carbon ﬂuorous ligand
(F10-AuNP). The low-energy behaviour of f-AuNPs allows NIMS
experiments to be carried out at energies that are below the
threshold for gold cluster formation (Supplementary Fig. 3), a
signiﬁcant advantage since these ion clusters can complicate the
mass spectrum in the low mass region. In addition, the low
energies used tend to create minimal background signal
compared with typical MALDI matrices (Supplementary
Figs 4–15).
The survival yield plot in Fig. 2 shows that the f-AuNPs
performed exceptionally well in terms of fragmentation as
compared with the C8-AuNPs. We observed that fragmentation
begins immediately at the threshold energy required for
desorption and levels out at B20% survival for C8-AuNP,
whereas the F8-AuNP maintained 100% survival over 0.25–0.50mJ
and reached a steady state of 60% at 1.25 mJ. These results suggest
that the ﬂuorous-thiol functionality effectively insulates the
sample from the potentially damaging thermal energy from the
irradiated AuNPs. This is further evidenced by the observation
that the longer ﬂuorinated alkane thiol functionalized F10-AuNPs
maintain 100% survival over a longer range (0.34–0.80 mJ) as
presumably the longer chain better insulates the analyte from the
heat generated at the particle surface. It is also interesting to note
that fragmentation begins at energies far below the threshold for
desorption of bare nanoparticles, showing the inherent harshness
of nanoparticle-based thermal desorption. The comparison to be
made with MALDI-MS is more nuanced; at very low energies,
desorption does not occur in MALDI-MS, while it does occur
using f-AuNP with essentially no damage to the molecular ion. As
the energy approaches the threshold for MALDI, the survival
yield for f-AuNPs begins to decrease and continues to decrease at
a slower rate than MALDI until both desorption methods reach a
steady state of 60% at 1.25 mJ.
Generally, we observed that the f-AuNPs outperform MALDI
at low energy and perform comparably at higher energies. The
signal-to-noise ratios plotted in Fig. 2 show that the particles
perform better than both MALDI and the C8-AuNP in terms of
the generation of [M]þ signal. This result is again most likely due
to the low energy requirements for this type of desorption/
ionization. In addition, the longer chain appears to perform
slightly better than the shorter chain. The length of the chain
appears to shift and extend the optimal energy range for this
experiment; however, in both cases, it should be noted that the
maximum signal-to-noise occurs at energies above 100% survival.
Furthermore, it could be the case that the trend would continue
with the use of a perﬂuorododecanethiol (F12); however, this
ligand was not readily available.







































Figure 2 | Soft ionization with f-AuNPs. (a) The diameter of AuNPs
increases from 3.5±0.5 nm to 6.0±1.4 nm after laser irradiation.
(b) TEM images of AuNPs before and after laser irradiation. Scale bar,
10 nm. (c) Survival yield versus laser energy plot of methoxybenzyl
pyridinium for F8-AuNP, F10-AuNP, C8-AuNP and MALDI (error bars are
s.d.). (d) Signal-to-noise versus laser energy plot for [M]þ (m/z¼ 200)
for F8-AuNP, F10-AuNP, C8-AuNP and MALDI (error bars are s.d.).
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In addition to the low-energy requirements of the f-AuNP
observed in the survival yield experiments, scanning electron
microscopy (SEM) data indicate that the desorption process is
particularly soft. Unlike the typical ablation ‘craters’ observed in
MALDI-MS analysis of the tissue (Supplementary Fig. 16), we
observed plateau-like structures in the f-AuNP experiments.
Figure 3 shows a slice of lung tissue that was spotted with the
f-AuNP solution and irradiated with a Nd:YAG laser. In the
treated area, the laser pulses create raised protrusions. Outside of
this f-AuNP-coated region, no protrusions were formed. Inter-
estingly, the laser pulses that occurred at the interface create
partial plateau structures. We suspect that the protrusion of the
surface following laser radiation is a side product brought about
by the heating of the f-AuNPs. We speculate that the heat of the
f-AuNPs vaporizes the more volatile components in the tissue,
creating the plateau-like effect, however this phenomenon
requires further investigation.
NIMS and SEM imaging of bioﬁlms. The overarching goals of
this technology are to increase both the accessibility and the
functionality of nanostructure-based imaging. Using f-AuNPs as
a platform accomplishes these goals by adding multiple methods
of imaging capabilities. To this point, another advantage of
f-AuNPs is their solubility in biologically inert ﬂuorocarbon
solvents that can be applied to the top of a tissue sample. This
contrasts to classic silicon NIMS experiments, which require that
the sample be thinly sliced and placed on top of a nanostructured
surface. We tested the versatility of the f-AuNPs on a bioﬁlm
sample that would not be immediately accessible to silicon
nanostructure-based techniques due to the thickness of the
sample38. To analyse these samples, the aclar substrates that the
bioﬁlms were grown on were attached directly to the target plate
where, following desiccation, the f-AuNPs were deposited drop
wise.
The NIMS data shown in Fig. 4 illustrate that f-AuNP can be
used to initiate desorption/ionization from these irregular bioﬁlm
surfaces. This image compares two bioﬁlm cultures of Desulfovi-
brio vulgaris (DVH)—one that was grown in balanced conditions
and one that was grown in stressed conditions. Stressed
conditions refer to an electron acceptor-limited (EAL) environ-
ment, which affects the bioﬁlm growth of sulfate reducing
bacteria, like DVH. The mass spectra extracted from the balanced
and stressed bacteria (Fig. 4) show several differences, the most
dramatic one at m/z 551, which has been mapped to the right of
the mass spectra in Fig. 4. This ion was putatively identiﬁed
(Supplementary Fig. 17 and Supplementary Table 1) diglyceride
(16:0/16:0) (ref. 39) and might be indicative of perturbed
metabolism in the stressed bacteria; however, this is still a very
preliminary ﬁnding. In addition, f-AuNPs were successfully
applied to the bacteria sample, following ﬁxation and
dehydration, to act as a contrast agent for the comparatively
high-resolution SEM images shown in Fig. 4. Surprisingly, we
found that the density of the EAL bacteria was in fact increased
relative to the balanced bacteria. This result was conﬁrmed using
a standard SEM procedure and is currently under further
investigation.
NIMS and X-ray lCT imaging of mouse lung tissue. The suc-
cess of the mass spectrometric detection of metabolites using
f-AuNPs (Fig. 4) has allowed for the further integration of the
f-AuNPs NIMS analysis with mCT. Together these two modes of
imaging allow for the correlation of three-dimensional anatomical
(structural) and molecular information (Supplementary Fig. 18).
For example, this has been demonstrated in the analysis of
metastatic mouse lungs. Speciﬁcally, 500 ml of the biologically
inert f-AuNP solution was intratracheally introduced into mouse
lungs and immediately distributed into the lung tissue. The liquid
ventilated lung was then embedded into OCT (optimal cutting
temperature) material and preserved in  80 C until analysis.
The mouse lung was then imaged with mCT to construct high-
resolution three-dimensional image (Fig. 5 Supplementary
Video 1). F-AuNPs were well distributed into the lung tissue
and characterized the airway and porosity of the lung. The blood
vessels appear as dark areas and the regions of the lungs carrying
metastases revealed dark spots consistent with the exclusion of
nanoparticle from the metastatic lesions (Supplementary Fig. 19).
To obtain molecular information from liquid ventilated
metastatic lung tissue, OCT-embedded lungs were sectioned
(20 mm) and analysed. Since the f-AuNPs solution had been
passed through the trachea into the lung, no additional f-AuNPs
were applied to the tissue. A mass spectrometry image of the
f-AuNP-ventilated left lobe of the lung is shown in Fig. 5. In
general, mass spectrometry analysis is a multiplexed analysis
where multiple molecular ions can be simultaneously detected in
one experiment. Here we chose to map a phosphatidylcholine
(Supplementary Fig. 20) at m/z 756 to demonstrate molecular
information and its distribution in this tissue (Fig. 5). To conﬁrm
that the areas lacking nanoparticle signal did contain cancerous
tissue, metastases in an intact liquid ventilated mouse lung were
identiﬁed by haematoxylin and eosin staining and compared with
an adjacent NIMS image (Supplementary Fig. 19). To better
access these structures, it might be possible to approach the
metastases from the blood stream by perfusing the animal with a
synthetic blood form of the f-AuNP or to coat the tissue following
sectioning (Supplementary Fig. 21).
To enable NIMS and X-ray mCT imaging of blood vessels
in situ, we took advantage of ﬂuorocarbons utility as a blood




Figure 3 | Characterization of desorption/ionization using ﬂuorinated nanoparticles. (a) Silicon substrate with a thaw-mounted section of
mouse lung spotted with a f-AuNP solution. (b) SEM characterization of the mouse lung section spotted with f-AuNPs after laser irradiation.
(c) The plateau-shaped spots (50–60mm in diameters) formed on the tissue surface after laser irradiation.
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perﬂuordecalin, which was emulsiﬁed to approximate the only
the Food and Drug Administration-approved ﬂuorocarbon-based
blood substitute40. The f-AuNP emulsion was perfused into the
circulatory system to demonstrate the ability to obtain structural
and chemical information from the circulatory system associated
with the lung (Supplementary Fig. 22) as well the liver
(Supplementary Fig. 23) of the mouse. In addition, we also
applied these imaging approaches to investigate the structural and
chemical effects of hyperoxia on the lung tissue of juvenile mice
(Supplementary Figs 24 and 25).
NIMS for analysis of central carbon metabolites. The majority
of central carbon metabolites are anionic and thus are better
suited for analysis in negative ion mode imaging mass spectro-
metry. One successful approach used for the in situ ionization
and imaging of central carbon metabolites employs amine-
functionalized initiators30 and MALDI matrices31. Presumably,
these adjuvants work well because the basic amine group acts as a
proton acceptor to promote MH production. Thus, to enable
the application of this imaging platform to the analysis of central
carbon metabolites in negative ionization mode, we have to
enrich the ﬂuorocarbon solvent with the basic initiator
1H,1H,2H,2H,3H,3H-perﬂuoroundecylamine (PFUA).
As it was not clear that the f-AuNPs would transfer the
requisite energy to the initiator molecule needed to induce
desorption/ionization, we tested the enriched f-AuNPs using a
standard mixture of nine metabolites in negative mode. A mass
spectrum generated from this experiment is shown in Fig. 6; in
addition to the peaks for each individual metabolite, we also
observe peaks for Au and PO4H2 . We attribute the
emergence of these ions to the higher energy used in this
experiment. The spectra in Supplementary Fig. 3 show that
under the standard operation energy of 1.4 mJ no Au ions are
formed; the addition of PFUA, however, increased the energy
requirement to B2 mJ. Just as the energy threshold increases
with chain length (Fig. 2), the incorporation of the PFUA shifted
this threshold even further by ostensibly adding a second barrier
between the AuNP and the analyte. However, even at this
increased energy, the enriched f-AuNPs performed well in
negative ion mode.
The enriched f-AuNPs were then used to demonstrate central
carbon metabolite imaging in tissue using negative ionization
mode. The enriched particles were applied to the top of a sagittal
slice from one half of a bifurcated mouse brain after desiccation.
In Fig. 6, we have mapped the ions corresponding to lactate,
glutamate and docosahexenoic acid. The presence of each
mapped metabolite was then conﬁrmed by LC-MS/MS analysis
of the second half of the brain. Here we have demonstrated that
this platform like Si-based NIMS30 has the ability to use
specialized initiators to expand the number of metabolites that
























Figure 4 | NIMS and SEM imaging using ﬂuorinated AuNPs. (a) Mass spectra generated from two regions of interest in the f-AuNP MSI—one
corresponds to the bioﬁlm grown in balanced media (blue) and one corresponding to the bioﬁlm grown in EAL media (red). The inset (b) shows the ion


















Figure 5 | NIMS and lCT imaging using ﬂuorinated AuNPs. (a) Mass
spectra generated from a single-lobe metastatic mouse lung ventilated with
f-AuNPs. The inset (b) shows the ion image for m/z 756. (c) mCT images of
the same lobe of the f-AuNP-ventilated metastatic mouse lung at 0 and
135 where gold indicates the surfaces of the f-AuNP-ventilated lung and
silver represents the volume.
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Discussion
Fluorinated AuNPs (f-AuNPs) were designed to facilitate NIMS
as well as act as contrast agents for EM and mCT. An important
feature of the f-AuNPs is that they promote a gentle laser
desorption/ionization mechanism facilitating intact molecular ion
formation with little background interference or molecular ion
fragmentation. The utility of AuNPs for structural mCT
measurements is well established but the primary advance of
employing ﬂuorinated ligands to these structures has allowed for
structural data (mCT) to be combined for the ﬁrst time with
molecular mass spectrometry information (f-AuNPs NIMS).
This multimodal imaging approach is particularly useful for
performing mass spectrometry-based metabolite imaging, where
correlating metabolite concentrations with anatomical structure is
key to data interpretation. The ﬂuorocarbon liquid component of
the method affords versatility in the delivery of the agent, which
can be carried out via direct coating, liquid ventilation or
perfusion allowing analysis of morphologically diverse biological
samples.
Methods
Chemicals. Octanethiol-functionalized AuNPs (2–4 nm DLS, 2% w/v in toluene)
and ﬂuorinated ligands 1H,1H,2H,2H-perﬂuorodecanethiol (fC10) and
1H,1H,2H,2H-perﬂuorooctanethiol (fC8), methoxybenzyl pyridinium chloride and
perﬂuorodecalin were purchased from Sigma-Aldrich (St Louis, MO, USA) and























































































Figure 6 | NIMS for the analysis of central carbon metabolites. (a) A mass spectrum for nine metabolites in a standard mixture. (b–d) NIMS images
of a sagittal slice of a mouse brain collected in negative ion mode. Each image is paired with (e–g) the structure of the identiﬁed metabolite and
(h–j) tandem MS data that were collected using LC-MS/MS.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6998
6 NATURE COMMUNICATIONS | 6:5998 | DOI: 10.1038/ncomms6998 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
1H,1H,2H,2H,3H,3H-perﬂuoroundecylamine was from Santa Cruz Biotechnology
(Dallas, TX).
Nanoparticle synthesis. Octanethiol-functionalized AuNPs were in toluene with
a concentration of 20mgml 1. One ml of octanethiol-functionalized AuNPs
(20mg) was added to B20ml of ethanol to precipitate the AuNPs with cen-
trifugation at 4,000 r.p.m. for 15min. The precipitated AuNP were then washed
with acetone, brieﬂy sonicated and centrifuged again. The cleaning procedure was
repeated three times before being dissolved in 1ml of hexane. The AuNP solution
(1ml) was then analysed using LDI-MS to test for the presence of tetraoctyl
ammonium bromide by monitoring the tetraoctyl ammonium ion at m/z 466,
which is commonly used as a phase transfer additive in nanoparticle synthesis.
More acetone washes were conducted until tetraoctyl ammonium ion was not
detected. An additional 1ml of hexane and 400 ml of 1H,1H,2H,2H-per-
ﬂuorooctanethiol (fC8) or 1H,1H,2H,2H-perﬂuorodecanethiol (fC10) was added
and the vial was purged with nitrogen gas to remove air. The solution was stirred
for one to three days until AuNPs precipitated. The solvent was evaporated with
nitrogen gas ﬂow and nanoparticles were washed three times with hexane, three
times with acetone and two times with 1:1:1 methanol/acetone/water, respectively,
to remove excess ligand and impurities. Following washing, the AuNP was dried in
the oven (B80 C) for several minutes and stored as a solid. Before use, the AuNP
was dissolved in tetradecaﬂuorohexane (PFH) at 3mgml 1 for mass spectrometry
and electron microscopy analyses and 10mgml 1 in perﬂuorodecalin for mouse
lung perfusion experiments.
Enriched f-AuNPs were made by dissolving 3mgml 1 f-AuNPs into 5%
1H,1H,2H,2H,3H,3H-perﬂuoroundecylamine perﬂuorodecalin solution.
The blood substitute f-AuNP solution was made by combining 50%
20mgml 1 f-AuNP/preﬂuorodecilin and 50% Pluronic F-68 (0.5%) in Milli-Q
water. The immiscible solutions were sonicated for 5min at 50% duty cycle with a
probe sonicator.
Electron microscopy characterization. For TEM imaging, ﬂuorinated AuNPs
were deposited on 400 mesh copper grids and characterized by a Philips CM100
electron microscope (FEI, Hillsborough, OR) at 80 kV. Images were collected using
a Megaview III CCD camera (Olympus Soft Imaging Solutions, Mu¨nster,
Germany). Fluorinated AuNPs deposited on copper grids were also irradiated with
(355 nm, laser energy 6.6 mJ, 2,000 shots), and then measured with TEM. For SEM
analysis, 10ml of 3mgml 1 ﬂuorinated AuNPs in PFH were ﬁrst deposited onto
mouse brain or lung tissue which was then irradiated by a laser with a predeﬁned
250-mm step size. Subsequently, the samples were imaged with a Hitachi S4800
SEM at 5 kV. SEM was done on bioﬁlms from the same batch. Aclar slides with
adhered bioﬁlm were aldehyde ﬁxed (2.5% w/v glutaraldehyde, 2.0% w/v paraf-
ormaldehyde, 0.05M sodium cacodylate buffer pH 7.0) overnight. Samples were
rinsed with double-distilled H2O and ethanol dehydrated. Critical point drying was
then carried on the samples using CO2 and spotted with f-AuNP solution
(1mgml 1). Samples were also viewed on a Hitachi S4800 SEM.
Bacterial strains and growth conditions. DVH RCH1 was obtained from
Dr Romy Chakraborty (Lawrence Berkeley National Lab) and was isolated from
Cr-contaminated groundwater at the U.S. Department of Energy Hanford reser-
vation. DVH RCH1 was grown in LS4D medium, which contains lactate as the
carbon source and electron donor and sulfate as the electron acceptor41. Lactate
and sulfate concentrations were altered to create balanced and EAL conditions. The
balanced condition was deﬁned as 60mM sodium lactate and 30mM sodium
sulfate and the EAL condition was deﬁned as 50mM sodium lactate and 10mM
sodium sulfate. DVH RCH1 was grown as a bioﬁlm under continuous ﬂow
conditions in a modiﬁed Center for Disease Control reactor. Exponential phase
cells were inoculated into a reactor containing balanced or EAL lactate–sulfate
media (LS4D) and were grown in batch mode for 48 h. Bioﬁlms were grown at
room temperature (20–23 C), with a dilution rate of 0.04 per hour, stirred at
60 r.p.m. and the headspace was continually purged with sterile N2 gas to maintain
anaerobic conditions. Coupons of aclar (7.8m.i.l. thickness; Electron Microscopy
Sciences, Hatﬁeld, PA) supported by glass slides were submerged in the reactor
body as a surface for bioﬁlm growth. Aclar coupons were removed from the reactor
after 144, rinsed three times in ice-cold PBS, wicked dry and ﬂash frozen in liquid
nitrogen. Samples were stored at  80 C until analysis.
Animals and lCT imaging. All animal work complied with the National Institutes
of Health and institutional guidelines (TSRI is AAALAC, International accredited).
Female 11-week-old CB17-PrkdcSCID mice were euthanized by overdose of iso-
ﬂurane before exsanguination by cutting the abdominal aorta. A small incision was
performed in the trachea to insert a 20 gauge blunt needle, which was secured by a
piece of suture. Approximately 500 ml of 10mgml 1 f-AuNP in PFH solution was
then injected into the lungs up to full lung inﬂation. Intact lungs were immediately
harvested, placed in OCT compound embedding medium, frozen in liquid nitrogen
and stored at  80 C before analysis.
For the hyperoxia experiment, the experimental group consisted of C57BL/6J
P7 pups (7 days old) exposed to 75% oxygen for 5 days and returned to room air at
P12 (12-day-old pups). The control group consisted of age-matched pups raised in
normoxia (21% O2) for the same period. Pups were killed at P12. As was the case
with adult mice, the pups were euthanized by overdose of isoﬂurane before
exsanguination by cutting the abdominal aorta. Ventilation of the f-AuNPs in this
case was carried out directly via the mouth to the trachea. Approximately 250 ml of
10mgml 1 f-AuNP in perﬂuorodecalin solution was then injected into the lungs
up to full lung inﬂation. Again, the intact lungs were immediately harvested, placed
in OCT compound embedding medium, frozen in liquid nitrogen and stored
at  80 C before analysis.
For the blood substitute experiment, a male mouse (C57BL/6J, 24 days of age)
was anaesthetized with isoﬂurane and the heart was exposed. A 23-gauge needle
attached by tubing to a syringe was inserted into the left ventricle, the right atria
was pierced and 40ml saline was perfused through the animal at a rate of
3.1mlmin 1 to clear all of the blood. A three-way valve was switched so that 3ml
of the f-AuNP blood substitute was then pumped through the mouse at the same
rate. The lung and liver were harvested and imbedded in OCT until mCT analysis.
The intact mouse lungs and liver were imaged by mCT (vivaCT 75; Scanco
Medical AG; Basserdorf, Switzerland) in standard resolution using the following
parameters: 55 kVP, 145mA, 300-ms integration time and 41-mm voxel size. The
scanning protocol was programmed to acquire images via a rotating gantry,
resulting in a total of 500 step-projections per scan. The projections were
reconstructed with a matrix of 1,024 1,024 using Scanco’s mCT Tomography
V5.4C software. The two-dimensional binary digital imaging communication ﬁles
obtained from Scanco’s software were later analysed using 64-bit OsiriX v.3.9.2
(Pixmeo; Geneva, Switzerland) software.
Mass spectrometry analysis and imaging. For the analysis of standard com-
pounds, 0.5 ml of f-AuNP solution (3mgml 1) was ﬁrst deposited onto a p-type
silicon chip and allowed to air dry. Then, 0.1–0.5 ml of standard compound solution
was deposited on top of dried f-AuNP layer and dried under vacuum. An AB
SCIEX TOF/TOF 5800 MS system was used for data collection. The instrument
was operated at reﬂectron mode with a repetition frequency of 400Hz and
an accelerating voltage of 15 kV. Each sample spectrum was averaged from
400 laser shots.
Plasma was analysed using a MALDI SYNAPT G2S (Waters, Milford, MA)
equipped with a Nd:YAG laser (355 nm) with a repetition frequency of 1,000Hz
and variable laser energy (8–10 mJ). Nitrogen was used in the ion mobility cell and
the mobility experiments were collected with a variable wave velocity of 320 to
900m s 1 for the 50 to 1,200m/z region.
Mouse lung and liver tissue treated with AuNPs was sliced with a Leica CM1900
cryostat to a thickness of 20mm, and then thaw-mounted directly onto p-type
silicon chip. The tissues were directly imaged by an AB SCIEX TOF/TOF 5800 MS
system without additional sample preparation. Tissue slices were imaged with a
100 mm step size and each recorded mass spectrum resulted from the average of
400 laser shots. Representative sections of the cancer metastasized lungs were
collected on Superfrost Plus slides and stained with hematoxylin and eosin using
routine histological techniques.
LC-MS/MS. Lung tissue and bioﬁlm samples were analysed using reversed phase
liquid chromatography/MS analysis in ESI-positive mode. The extracts were
analysed on 6550 iFunnel QTOF mass spectrometer (Agilent Technologies)
interfaced with 1200 series HPLC system (Agilent Technologies). For reversed
phase liquid chromatography separation, 0.1% formic acid in water was used as
mobile phase A and 0.1% formic acid in acetonitrile was used as mobile phase B.
The metabolite extract was loaded onto a C18 column using 5% mobile phase B at
a ﬂow rate of 100 ml min 1 and resolved using a linear gradient of 5% B–95% B
over 60min.
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